What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Pharmacology
- Surgery
The scientist’s investigation covers issues in Pharmacology, Pharmacokinetics, Oral administration, Crossover study and Cmax.
His Pharmacology study combines topics in areas such as CYP3A4, Gemfibrozil and Pravastatin.
His Pharmacokinetics research integrates issues from Endocrinology, Repaglinide, Genotype and CYP2C8.
His studies in Oral administration integrate themes in fields like Hypnotic, Midazolam and Grapefruit juice.
In his research on the topic of Cmax, Lovastatin Acid is strongly related with Lovastatin.
His Simvastatin course of study focuses on Hydroxymethylglutaryl-CoA reductase and Enzyme inhibitor and Atorvastatin.
His most cited work include:
- Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance (651 citations)
- Pharmacokinetic interactions with rifampicin : clinical relevance. (524 citations)
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake (456 citations)
What are the main themes of his work throughout his whole career to date?
Pertti J. Neuvonen mostly deals with Pharmacology, Pharmacokinetics, Crossover study, Anesthesia and Oral administration.
Pertti J. Neuvonen has researched Pharmacology in several fields, including CYP3A4, CYP2C8 and Gemfibrozil.
His studies deal with areas such as Endocrinology, Repaglinide and Antibacterial agent as well as Pharmacokinetics.
His Repaglinide research includes elements of SLCO1B1 and Genotype.
His work on Midazolam, Analgesic and Local anesthetic as part of general Anesthesia research is frequently linked to Oxycodone, bridging the gap between disciplines.
His Oral administration research focuses on subjects like Hypnotic, which are linked to Sedative.
He most often published in these fields:
- Pharmacology (72.73%)
- Pharmacokinetics (61.31%)
- Crossover study (28.96%)
What were the highlights of his more recent work (between 2011-2021)?
- Pharmacology (72.73%)
- Pharmacokinetics (61.31%)
- Anesthesia (26.85%)
In recent papers he was focusing on the following fields of study:
Pertti J. Neuvonen spends much of his time researching Pharmacology, Pharmacokinetics, Anesthesia, Crossover study and CYP2C8.
His work carried out in the field of Pharmacology brings together such families of science as Metabolite, Clopidogrel and CYP3A4.
His Pharmacokinetics study integrates concerns from other disciplines, such as Ketamine and Ticlopidine.
His research investigates the connection between Anesthesia and topics such as Adverse effect that intersect with issues in Heart rate.
His study on Crossover study is intertwined with other disciplines of science such as Endocrinology, Internal medicine and Dose–response relationship.
His research in CYP2C8 intersects with topics in Gemfibrozil and Repaglinide.
Between 2011 and 2021, his most popular works were:
- SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. (328 citations)
- Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions (86 citations)
- Glucuronidation Converts Clopidogrel to a Strong Time‐Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug–Drug Interactions (86 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Pharmacology
- Surgery
His scientific interests lie mostly in Pharmacology, Pharmacokinetics, Metabolite, CYP3A4 and CYP2C8.
His Pharmacology study combines topics from a wide range of disciplines, such as Clopidogrel and Pharmacogenetics.
He integrates several fields in his works, including Pharmacokinetics and Crossover study.
His study in Metabolite is interdisciplinary in nature, drawing from both Cytochrome P-450 CYP3A and In vivo.
His CYP2C8 research incorporates themes from Gemfibrozil and Repaglinide.
His work deals with themes such as SLCO1B1, Lovastatin, Genotype and HMG-CoA reductase, which intersect with Simvastatin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
